Medplus Shares Slide 4.8% on Q1 Miss

  Published 8 months ago

Medplus Health fell 4.8% after Q1 miss; Nomura cut target, citing rising costs and slower revenue growth.

  • Nomura maintained “buy” but trimmed target to Rs 1,030, implying 12.1% upside from current levels.
  • Q1 EBITDA missed due to elevated employee expenses; FY26–27 estimates cut by 15–22%.
  • Despite the drop, stock is still up 5.2% YTD; median analyst target stands at Rs 1,087.5.

You might like these

Govt Pushes Healthy Eating at Work

Meta Adds DMs to Threads, Eyes User Growth Over Revenue

AbhiBus Partners with CheckMyBus for Global Bus Travel

Reliance, Meta JV fuels India’s AI leap

SEBI Tightens SIF Investment Norms

Sonata Software Q1 Revenue Rises 17%

Zaggle Acquires Golf Travel Firm Greenedge

News that matters the most ⚡